Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 302-306

  Petschow, Bryon W ^a   Batema, Rosanne P ^a   Ford, Lorna L ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECANOIC ACID; LAURIC ACID; MEDIUM CHAIN FATTY ACID; METRONIDAZOLE; MONOACYLGLYCEROL; OCTANOIC ACID; OCTANOIN; TETRACYCLINE;

ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; DRUG RESISTANCE; HELICOBACTER PYLORI; NONHUMAN; PH; PRIORITY JOURNAL;

EID: 0030025634     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.302     Document Type: Article

References (30)

1. Annibale, B., E. Rauws, and V. Savarino. 1992. Long-term therapy of duodenal ulcer disease. Gastroenterol Int. 5:109-112.
2. Bayliss, M. 1936. Effect of the chemical constitution of soaps upon their germicidal properties. J. Bacteriol. 31:489-504.
3. Borgstrom, B., A. Dahlqvist, G. Lundh, and J. Sjovall. 1957. Studies of intestinal digestion and absorption in the human. J. Clin. Invest 36:1521-1536
4. Christensen, A. H., R. P. H. Logan, L. A. Noach, and T. Gjørup. 1994. Do clinicians accept the role of Helicobacter pylori in duodenal ulcer disease? A survey of European gastroenterologists and general practitioners J Intern Med. 236:501-505.
5. Conley, A. J., and J. J. Kabara. 1973. Antimicrobial action of esters of polyhydric alcohols. Antimicrob. Agents Chemother. 4:501-506.
6. Faber, J., R. Goldstein, O. Blondheim, H. Stankiewicz, A. Darwashi, J. A. Bar-Maor, A. Gorenstein, A. I. Eidelman, and S. Freier. 1988. Absorption of medium-chain triglycerides in the stomach of the human infant. J. Pediatr Gastroenterol. Nutr 7:189-195.
7. Fernandes, P. B., C. W. Hanson, J. M. Stamm, C. Vojtko, N. L. Shipkowitz, and E. St. Martin. 1987. The frequency of in vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo. J. Antimicrob. Chemother. 19:449-465.
8. Galbraith, H., and T. B. Miller. 1973. Physicochemical effects of long chain fatty acids on bacterial cells and their protoplasts. J. Appl. Bacteriol. 36:647-658.
9. Galbraith, H., and T. B. Miller. 1973. Effects of long chain fatty acids on bacterial respiration and amino acid uptake. J. Appl. Bacteriol. 36:659-675.
10. Glassman, H. N. 1949. Surface active agents and their application in bacteriology Bacteriol. Rev. 12:105-148.
11. Glupczynski, Y., A. Burette, E. de Koster, et al. 1990. Metronidazole resistance in Helicobacter pylori. Lancet 335:976-977. (Letter.)
12. Graham, D. Y., G. M. Lew, H. M. Malaty, et al. 1992. Factors influencing the eradication of Helicobacter pylon with triple therapy. Gastroenterology 102: 493-496.
13. Hardy, D. J., C. W. Hanson, D. M. Hensey, J. M. Beyer, and P. B. Fernandes. 1988. Susceptibility of Campylobacter pylori to macrolides and fluoroquinones. J. Antimicrob. Chemother. 22:631-636.
14. Hazell, S. L., and D. Y. Graham. 1990 Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori. J Clin Microbiol. 28:1060-1061.
15. Kabara, J. J. 1978. Fatty acids and derivatives as antimicrobial agents. A review, p. 1-14. In J. J. Kabara (ed), The pharmacological effects of lipids. American Oil Chemist Society, Champaign, Ill
16. Kabara, J. J., D. M. Swieczkowski, A. J. Conley, and J. P. Truant. 1972. Fatty acids and derivatives as antimicrobial agents. Antimicrob. Agents Chemother. 2:23-28.
17. Kato, N., and I. Shibasaki. 1975. Comparison of antimicrobial activities of fatty acids and their esters. J. Ferment. Technol. 53:793-801.
18. Kato, N., and I. Shibasaki. 1976. Combined effect of citric and polyphosphoric acids on the antibacterial activity of monoglycerides. J. Antibact. Antifungal Agents (Jpn.) 4:254-261.
19. Knapp, H. R., and M. A. Melly. 1986 Bactericidal effects of polyunsaturated fatty acids. J. Infect. Dis. 154:84-94.
20. Kodicek, E. 1949. The effect of unsaturaled fatty acids on gram-positive bacteria. Soc Exp. Biol Symp 3:217-232
21. Marshall, B. J. 1993. Treatment strategies for Helicobacter pylori infection. Gastroenterol Clin. North Am 22:183-198
22. Moss, S., and J. Calam. 1992. Helicobacter pylori and peptic ulcers: the present position Gut 33:289-292.
23. National Committee for Clinical Laboratory Standards. 1985. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, Pa.
24. Nieman, C. 1954. Influence of trace amounts of fatty acids on the growth of microorganisms. Bacteriol. Rev. 18:147-163
25. Penston, J. G. 1994. Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment. Pharmacol. Ther. 8:369-389. (Review)
26. Rauws, E. A. J., W. Langenberg, H. J. Houthoff, H. C. Zanen, and G. N. J. Tytgat. 1988. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33-40.
27. Rubinstein, G., K. Dunkin, and A. J. Howard. 1994. The susceptibility of Helicobacter pylori to 12 antimicrobial agents, omeprazole and bismuth salts. J. Antimicrob Chemother. 34:409-413.
28. Sheu, C. W., and E. Freese. 1973. Lipopolysaccharide layer protection of gram-negative bacteria against inhibition by long-chain fatty acids. J Bacteriol. 115:869-875
29. Shibasaki, I., and N. Kato. 1978. Combined effects on antibacterial activity of fatty acids and their esters against gram-negative bacteria, p. 1-14. In J J. Kabara (ed.), The pharmacological effects of lipids. American Oil Chemist Society, Champaign, Ill
30. Thompson, L., A. Cockayne, and R. C. Spiller. 1994. Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: a possible explanation of the effect of diet on peptic ulceration. Gut 35:1557-1561.